VWDE Activators
VWDE Activators encompass a diverse array of chemical compounds that enhance the functional activity of VWDE through a variety of signaling mechanisms. Forskolin, by increasing cAMP levels, activates PKA, which may phosphorylate VWDE, resulting in its enhanced activity. This mechanism is shared by IBMX, which also raises cAMP levels by inhibiting its degradation. Sphingosine-1-phosphate activates the PI3K/Akt pathway, potentially causing post-translational modifications that increase VWDE activity. Similarly, PMA, through PKC activation, could lead to phosphorylation events that promote VWDE activity. Ionomycin, acting as a calcium ionophore, raises intracellular calcium levels, which can activate calcium-dependent kinases that might phosphorylate VWDE. Insulin, through its receptor, activates PI3K/Akt pathway, potentially leadingto phosphorylation of VWDE, enhancing its function. EGF, by activating the MAPK/ERK pathway, is another growth factor that can contribute to the activation of VWDE through downstream phosphorylation events.
The action of nitric oxide donors like SNAP, which release nitric oxide to activate guanylate cyclase and increase cGMP levels, can indirectly enhance VWDE activity through cGMP-dependent protein kinases. Thapsigargin's inhibition of the SERCA pump also leads to elevated cytosolic calcium levels, potentially activating calcium-dependent kinases that enhance VWDE activity. Bradykinin, by activating its receptors, initiates a cascade that increases intracellular calcium and may activate kinases to phosphorylate VWDE. Acetylcholine, through muscarinic receptors, activates PLC to produce second messengers that lead to PKC activation and subsequent phosphorylation of VWDE. Lastly, hydrogen peroxide acts as a redox signaling molecule, potentially influencing the activity of redox-sensitive kinases or phosphatases that modulate VWDE. Collectively, these VWDE Activators, through their targeted effects on cellular signaling, facilitate the enhancement of VWDE-mediated functions without the need for upregulating its expression or direct activation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, resulting in an increase of cyclic AMP (cAMP) levels within cells. Elevated cAMP levels can lead to the activation of cAMP-dependent protein kinase A (PKA), which may phosphorylate and thereby enhance the activity of VWDE through cAMP-responsive elements within the cell. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates sphingosine-1-phosphate receptors, triggering intracellular signaling cascades such as PI3K/Akt pathway. This activation can result in post-translational modifications of VWDE that enhance its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate and modulate various proteins. PKC activation can lead to the phosphorylation and consequent activation of VWDE, as part of the signal transduction associated with PKC. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. Elevated calcium levels can activate calcium-dependent protein kinases which may, in turn, phosphorylate and enhance the activity of VWDE. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor leading to the activation of the PI3K/Akt pathway, which can result in the phosphorylation of downstream targets including VWDE, thereby enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation in the cell. Increased levels of these cyclic nucleotides can enhance the activity of VWDE through cAMP- or cGMP-dependent pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels. This increase can activate calcium-dependent pathways that modulate the activity of VWDE. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates its receptors leading to the activation of PLC, which results in IP3 production and subsequent release of calcium from endoplasmic reticulum stores. The rise in calcium can activate various calcium-dependent kinases that phosphorylate VWDE, enhancing its activity. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
H2O2 can act as a signaling molecule affecting redox-sensitive pathways. It might activate redox-sensitive kinases or phosphatases that modulate the phosphorylation state and thus the activity of VWDE. | ||||||